Enrollment complete in ORACLE MS study of cladribine tablets

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Enrollment complete in ORACLE MS study of cladribine tablets

Postby MSUK » Wed Nov 17, 2010 2:25 am

Image

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the completion of patient enrollment in the ORACLE MS1 clinical study. This randomized, double blind, placebo-controlled, international Phase III trial is designed to evaluate the therapeutic effects of Cladribine Tablets on the time to conversion to multiple sclerosis (MS) in people with a first clinical event suggestive of the disease.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2090
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: Alainaluvsu